Cao C, Wang J, Bunjhoo H, Xu Y, Fang H. Risk profile of bevacizumab in patients with non-small cell lung cancer: A meta-analysis of randomized controlled trials. AO [Internet]. 2012 Feb. 1 [cited 2026 May 18];51(2):151-6. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/30608